Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10189831 Non-nucleoside reverse transcriptase inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 7, 2017
Date of Patent
January 29, 2019
Patent Application Number
15616756
Patent Citations Received
‌
US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing
0
‌
US Patent 11932884 High efficiency base editors comprising Gam
0
‌
US Patent 11999947 Adenosine nucleobase editors and uses thereof
0
‌
US Patent 11542496 Cytosine to guanine base editor
‌
US Patent 11542509 Incorporation of unnatural amino acids into proteins using base editing
‌
US Patent 11560566 Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
‌
US Patent 11566020 Pyridazinones as PARP7 inhibitors
‌
US Patent 11643652 Methods and compositions for prime editing nucleotide sequences
0
‌
US Patent 11268082 Nucleobase editors comprising nucleic acid programmable DNA binding proteins
‌
US Patent 11661590 Programmable CAS9-recombinase fusion proteins and uses thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10189831
Patent Primary Examiner
‌
Jean P Cornet

Find more entities like US Patent 10189831 Non-nucleoside reverse transcriptase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.